Evidence map›Paper›PMID 39537979›Full record

ArticleLeukemia2025

Correction: Aberrant BCAT1 expression augments MTOR activity and accelerates disease progression in chronic lymphocytic leukemia.

Qiangqiang Shao, Jedrzej Wykretowicz, Nan Hu, Karan Bedi, Mohamed Rizk, Isabella A Malek, Surinder Kumar, David B Lombard, Kerby Shedden, David Scott and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Qiangqiang ShaoDepartments of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, USA.
Jedrzej WykretowiczDepartments of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0002-2194-0128
Nan HuDepartments of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0002-8669-3287
Karan BediBiostatistics, University of Michigan, Ann Arbor, MI, USA.
Mohamed RizkDepartments of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, USA.
Isabella A MalekDepartments of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0009-0001-1395-487X
Surinder KumarPathology, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0003-0287-5612
David B LombardPathology, University of Michigan, Ann Arbor, MI, USA.
Kerby SheddenStatistics, University of Michigan, Ann Arbor, MI, USA.
David ScottSanford Burham Prebys Medical Discovery Institute, San Diego, CA, USA.ORCID http://orcid.org/0000-0002-8668-2449
Sami N MalekDepartments of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, USA. smalek@med.umich.edu.ORCID http://orcid.org/0000-0001-7734-4387

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39537979
PMCPMC11717690

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.